Comprehensive review examines targeted delivery and nanocarrier systems in various diseases, highlighting innovative strategies.
This comprehensive review examines the fundamental principles, diverse nanocarrier platforms, targeted delivery strategies, and clinical applications of nanomedicine across multiple disease domains. The article provides an in-depth analysis of established and emerging nanocarrier systems including liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrites, metallic nanoparticles, and biomimetic exosomes. Furthermore, it explores passive and active targeting mechanisms, stimuli-responsive drug delivery systems, and the integration of artificial intelligence and CRISPR technologies into nano therapeutics.
No takes yet. Share an insight, caveat, or question.
Muhammad Ahsan (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: